WO2010041908A3 - 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도 - Google Patents
판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도 Download PDFInfo
- Publication number
- WO2010041908A3 WO2010041908A3 PCT/KR2009/005804 KR2009005804W WO2010041908A3 WO 2010041908 A3 WO2010041908 A3 WO 2010041908A3 KR 2009005804 W KR2009005804 W KR 2009005804W WO 2010041908 A3 WO2010041908 A3 WO 2010041908A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pandurata extract
- boesenbergia pandurata
- panduratin derivative
- present
- metabolic disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/60—Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
- A23L13/67—Reformed meat products other than sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200980140126.6A CN102176906B (zh) | 2008-10-09 | 2009-10-09 | Panduratin衍生物或提琴形凹唇姜提取物的全新用途 |
JP2011530952A JP5619752B2 (ja) | 2008-10-09 | 2009-10-09 | パンドラチン誘導体またはボエセンベルギアパンドラタ抽出物の新規な用途 |
EP09819415.2A EP2351559B1 (en) | 2008-10-09 | 2009-10-09 | Novel use of panduratin derivative or boesenbergia pandurata extract |
US13/123,519 US8653143B2 (en) | 2008-10-09 | 2009-10-09 | Use of panduratin derivative or Boesenbergia pandurata extract |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2008-0099367 | 2008-10-09 | ||
KR20080099367 | 2008-10-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010041908A2 WO2010041908A2 (ko) | 2010-04-15 |
WO2010041908A3 true WO2010041908A3 (ko) | 2010-07-15 |
Family
ID=42101115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/005804 WO2010041908A2 (ko) | 2008-10-09 | 2009-10-09 | 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8653143B2 (ko) |
EP (1) | EP2351559B1 (ko) |
JP (1) | JP5619752B2 (ko) |
KR (1) | KR101135132B1 (ko) |
CN (1) | CN102176906B (ko) |
WO (1) | WO2010041908A2 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101698201B1 (ko) * | 2010-05-20 | 2017-01-19 | (주)뉴트리 | 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물을 포함하는 근육 증가 촉진, 항-피로 및 운동수행능력 향상용 조성물 |
KR101776001B1 (ko) * | 2016-03-04 | 2017-09-07 | (주)뉴트리 | 판두라틴 또는 핑거루트(보에센베르기아 판두라타) 추출물을 포함하는 골 손실 질환 치료, 예방 또는 개선용 조성물 |
KR102653110B1 (ko) | 2019-01-31 | 2024-04-01 | 경북대학교 산학협력단 | 보에센베르기아 풀케리마 추출물을 포함하는 식물병 방제용 조성물 |
KR102240935B1 (ko) * | 2019-06-04 | 2021-04-15 | (주) 노바렉스 | 핑거루트 추출물을 유효성분으로 함유하는 정제의 붕해성 및 저장안정성 향상을 위한 기술 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080018855A (ko) * | 2006-08-25 | 2008-02-28 | 연세대학교 산학협력단 | 판두라틴 에이 또는 그의 유도체의 신규한 용도 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9201076L (sv) * | 1992-04-06 | 1993-10-07 | Shimon Slavin | Användningen av gamla läkemedel för behandling av diabetes |
US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
JP2007186431A (ja) * | 2006-01-11 | 2007-07-26 | Pharmish Inc | 抗酸化組成物及び脳神経細胞保護用医薬組成物、抗酸化剤及び脳神経細胞保護剤、並びにそれらの使用方法 |
KR20080035032A (ko) * | 2006-10-18 | 2008-04-23 | 황재관 | 포자형성 미생물에 대한 포자살균제 |
KR20080099367A (ko) | 2007-05-09 | 2008-11-13 | 원광대학교산학협력단 | 수족사용 불능환자를 위한 안구전도를 이용한기기제어시스템 |
-
2009
- 2009-10-09 KR KR1020090096452A patent/KR101135132B1/ko active IP Right Grant
- 2009-10-09 EP EP09819415.2A patent/EP2351559B1/en active Active
- 2009-10-09 US US13/123,519 patent/US8653143B2/en active Active
- 2009-10-09 WO PCT/KR2009/005804 patent/WO2010041908A2/ko active Application Filing
- 2009-10-09 CN CN200980140126.6A patent/CN102176906B/zh active Active
- 2009-10-09 JP JP2011530952A patent/JP5619752B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080018855A (ko) * | 2006-08-25 | 2008-02-28 | 연세대학교 산학협력단 | 판두라틴 에이 또는 그의 유도체의 신규한 용도 |
Non-Patent Citations (2)
Title |
---|
HIRAMATSU ET AL.: "Molecular Intervention in Lifestyle-Related Diseases.", CRC PRESS, ISBN: 9780824729585, article SEE CHAPTER 21, pages: 243 - 276, XP008140472 * |
TRAKOONTIVAKORN, G. ET AL.: "Structural Analysis of a Novel Antimutagenic Compounds, 4-Hydroxypanduratin Am and the Antimutagenic Activity ofFlavonoids in a Thai Spice, Fingerroot (Boesenbergia pandurata Schult.) against Mutagenic Heterocyclic Amines", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY., vol. 49, no. 6, 2001, pages 3046 - 3050, XP018011280 * |
Also Published As
Publication number | Publication date |
---|---|
KR20100040270A (ko) | 2010-04-19 |
WO2010041908A2 (ko) | 2010-04-15 |
CN102176906B (zh) | 2014-07-02 |
JP5619752B2 (ja) | 2014-11-05 |
US8653143B2 (en) | 2014-02-18 |
CN102176906A (zh) | 2011-09-07 |
KR101135132B1 (ko) | 2012-04-13 |
US20120088840A1 (en) | 2012-04-12 |
JP2012505208A (ja) | 2012-03-01 |
EP2351559A2 (en) | 2011-08-03 |
EP2351559A4 (en) | 2012-03-28 |
EP2351559B1 (en) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009152189A8 (en) | Low dose topiramate/phentermine compostion and methods of use thereof | |
MY140576A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
WO2009091538A8 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
WO2010114824A8 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
NZ591810A (en) | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid | |
MY161607A (en) | Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions | |
MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
WO2011118976A3 (en) | Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same | |
NZ592217A (en) | Methods of treating pulmonary disorders with liposomal amikacin formulations | |
WO2008131469A3 (de) | Verfahren zur herstellung von hoch reinem 2,4 '-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen | |
MX2009009133A (es) | Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona. | |
UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
WO2011031063A3 (ko) | 항 4-1bb 항체를 포함하는 대사성 질환의 예방 또는 치료용 조성물 | |
WO2006115770A3 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
WO2010041908A3 (ko) | 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도 | |
WO2010087577A3 (ko) | 스페니쉬 오레가노 추출물, 여름세이보리 추출물 또는 카바크롤의 대사성 질환 치료를 위한 용도 | |
TW200724150A (en) | Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients | |
TW200637536A (en) | Compositions containing policosanol and theaflavin and their pharmaceutical uses | |
MX2008015323A (es) | Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion. | |
WO2009047779A3 (en) | Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form | |
MX2016008546A (es) | Reduccion de queloides utilizando alantoina topica. | |
WO2006053791A3 (en) | Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions | |
Hole et al. | Positive inotropic effect of the leaf extracts of parent and tissue culture plants of Coleus amboinicus on an isolated perfused frog heart preparation | |
WO2011090265A3 (ko) | 신코닌을 유효성분으로 포함하는 비만, 이상지방혈증, 지방간 또는 인슐린 저항성 증후군의 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980140126.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09819415 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2011530952 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009819415 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13123519 Country of ref document: US |